After functional depletion of CD4+ T and CD8+ T cells in 4T1 tumour-bearing BALB/c mice, the antitumour effects disappeared in TIOs+NIR3-treated mice (Fig. 6c and Supplementary Fig. 13g–i). The gene discussed is CD4; the disease is neoplasm.